Kidney Diseases: all 3,842 studies
Page 29 of 39. Open to participants first (491), then studies with results posted, then the rest; newest registration first within each.
- Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on HemodialysisWithdrawnNCT02015780Phase 3
- Heart Rate Variability & Fatty Acid Status: Haemodialysis PatientsCompletedNCT02014792
- Molecular MRI of the Fibrotic HeartTerminatedNCT02012725
- Prevention of Microvascular Complications in Overweight Diabetics With Surgery or Best MedicineWithdrawnNCT02011178Not applicable
- Glucose Containing and Glucose Free Hemodialysate in Type 2 Diabetic PatientsCompletedNCT02009514Phase 4
- Evaluating the Effect of Senna in Uremic PruritusCompletedNCT02008864Not applicable
- Effect of the Synbiotic Probinul-Neutro® on Gastrointestinal Symptoms and Plasma p-Cresol Level in Chronic Renal FailureCompletedNCT02008331Phase 4
- ACTH Treatment of APOL1- Associated NephropathyWithdrawnNCT02006849Not applicable
- The Phase I Clinical Study to Evaluate the Pharmacokinetics of Dw1029M in Healthy Male VolunteerCompletedNCT02004327Phase 1
- Renal Protection Using Sympathetic Denervation in Patients With Chronic Kidney DiseaseStatus unknownNCT02002585Phase 2
- Arterial Stiffness and Complication Risk in Type 2 DiabetesCompletedNCT02001532
- Surrogate Markers for Sudden Cardiac Death in Patients With Diabetes Mellitus and End Stage Renal DiseaseCompletedNCT02001480Not applicable
- Facilitating Anemia Treatment Risk Communication for Patients With Kidney Disease: Decision Aid TrialCompletedNCT01992926Not applicable
- Effect of the Consumption of Ferric Hydroxide Adipate on Urinary Phosphorus Excretion.CompletedNCT01991574Early Phase 1
- Losartan for Sickle Cell Kidney DiseaseCompletedNCT01989078Early Phase 1
- Effects of Vitamin D Replacement on Hormones Regulating Iron Metabolism in Individuals With Chronic Kidney DiseaseCompletedNCT01988116Early Phase 1
- Repository Study of Autosomal Dominant Polycystic Kidney DiseaseWithdrawnNCT01988038
- The Alberta Vascular Risk Reduction Community Pharmacy Project: RxEACHCompletedNCT01979471Not applicable
- Effectiveness of Integrated Care on Delaying Chronic Kidney Disease Progression in Rural Communities of ThailandCompletedNCT01978951Not applicable
- Effect of Hemodialysis on the PK of JTZ-951 in Subjects With End-stage Renal DiseaseCompletedNCT01978587Phase 1
- The Vascutek Rapidax™ II Post Market Surveillance RegistryTerminatedNCT01977508
- The Effect of Epogen and Venofer Dosing Management on Hemoglobin StabilityTerminatedNCT01975844Phase 4
- Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934CompletedNCT01975818Phase 2
- A Retrospective Multicenter Study to Determine 5-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-01 StudyCompletedNCT01974999
- Inflammatory Markers and Adverse Outcomes in Chronic Kidney DiseaseCompletedNCT01974713
- An Observational Study of Hemoglobin Stability in Chronic Kidney Disease Patients on Dialysis Treated With Mircera (Methoxy Polyethylene Glycol-epoetin Beta)CompletedNCT01974271
- Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal DiseaseCompletedNCT01971164Phase 1
- Sevelamer in Proteinuric CKDCompletedNCT01968759Phase 2
- Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)CompletedNCT01968668Phase 2
- Impact of Multidisciplinary Self-care Management of Diabetic Nephropathy on Quality of Life, Self-care Behavior, Glycemic Control, and Renal Function.CompletedNCT01967901Not applicable
- Effect of Restriction of Foods Containing Phosphorus AdditivesCompletedNCT01965379Not applicable
- ASP1517 Phase 2 Clinical Trial - Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis-CompletedNCT01964196Phase 2
- The Analysis of Correlation About the Spot Urine Sodium and the Blood Pressure in General Population According to the Income LevelCompletedNCT01960608
- Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy WastingCompletedNCT01958970Phase 1/2
- Fosrenol Post-marketing Surveillance in JapanCompletedNCT01955876
- Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease AloneCompletedNCT01955694Phase 2
- Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous NephropathyCompletedNCT01955187Phase 3
- Does ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED StudyCompletedNCT01951404Phase 4
- Central and Peripheral 24-h Blood Pressure Before and After 3 Month of CPAP Treatment in Obstructive Sleep ApneaStatus unknownNCT01951248Not applicable
- Nocturnal Blood Pressure - Central and Peripheral 24-h Blood Pressure in Chronic Kidney Disease.Status unknownNCT01951196
- Interdialytic Kt/V Variability Measurement With Adimea (IVP STUDY)CompletedNCT01947829
- Specific Enteral Nutrition in Malnourished, Dialysis Patients With Chronic Kidney Disease. Efficacy, Safety, Quality of LifeWithdrawnNCT01946841Phase 2
- Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis PatientsCompletedNCT01942460Phase 4
- To Determine the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic NephropathyCompletedNCT01935167Phase 2
- Efficacy and Safety of Hepatitis B Vaccine in Chronic Kidney Disease PatientsStatus unknownNCT01933412Phase 3
- Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression ControlStatus unknownNCT01932450Phase 2
- A Pilot Study for Pharmacokinetic Parameter of Colchicine in Patient Taking RifampinCompletedNCT01932268Phase 2
- Evaluation of the Bone Mineral Density and Muscle Mass in Patients Post Coronary Artery Bypass Graft Surgery With Chronic Kidney DiseaseCompletedNCT01932008
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy.CompletedNCT01923597Phase 2
- Different Doses of Oral Melatonin Supplements in Chronic Kidney Disease (CKD)-Associated Sleep DisordersStatus unknownNCT01922999Phase 2/3
- The Optiflow Patency and Maturation StudyCompletedNCT01921933Not applicable
- Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney DiseaseStatus unknownNCT01918488Not applicable
- Virtual Ward for Home DialysisCompletedNCT01912001Not applicable
- Two Vitamin D Dosing Strategies in Children With Chronic Kidney DiseaseCompletedNCT01909115Phase 1
- Hepatic Impairment Study With MDV3100 in Subjects With Mild and Moderate Hepatic Impairment Compared to a Healthy Control GroupCompletedNCT01901133Phase 1
- Impact of Sympathetic Renal Denervation- a Study in Patients After Renal TransplantationCompletedNCT01899456Not applicable
- Influence of DM on Artery Blood Flow and Complications After Radial Artery CannulationCompletedNCT01897857Not applicable
- Efficacy, Safety Study and Benefit of Alkali Therapy in Sickle Cell DiseaseTerminatedNCT01894594Phase 1
- A Study of Alegitazar in Patients With Type 2 Diabetes And Chronic Kidney Disease (Alerenal Study)WithdrawnNCT01893242Phase 3
- Efficacy of Antioxidant Therapy Compared With Enalapril in Sickle NephropathyStatus unknownNCT01891292Not applicable
- Chronic Kidney Disease in Relation to Alterations in Protein and Amino Acid Metabolism and FunctionWithdrawnNCT01890811Not applicable
- Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic NephropathyCompletedNCT01889277Phase 1/2
- Influence of Catheter-based Renal Denervation in Diseases With Increased Sympathetic ActivityStatus unknownNCT01888315Phase 1/2
- Cognitive Impairment and Imaging Correlates in End Stage Renal DiseaseCompletedNCT01883349
- Treatment of Resistant Hypertension by Renal Sympathetic Denervation in Patients Undergoing Dialysis TherapyTerminatedNCT01881035Not applicable
- Study of Standardized Treatment of Integrative Medicine With the Severe IgA NephropathStatus unknownNCT01879514Not applicable
- The Effect of Intradialytic Exercise on the Functional Capacity of Hemodialysis PatientsCompletedNCT01877863Not applicable
- PK of Serelaxin in Severe Renal Impairment and ESRDCompletedNCT01875523Phase 1
- Role of Sleep Apnea and Sympathetic Activity in Resistant Hypertensive Patients.CompletedNCT01875341Phase 3
- Study on Colonic Fermentation in Chronic Kidney Disease PatientsCompletedNCT01874210
- Examination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing HemodialysisCompletedNCT01872026Phase 1
- Preventive Effect of Pitavastatin on Contrast-Induced Nephropathy in Patients With Renal DysfunctionStatus unknownNCT01871792Phase 4
- CSPPT- Chronic Kidney Diseases StudyWithdrawnNCT01871740Phase 4
- Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes (SONATA Study)CompletedNCT01869881Phase 4
- Severe Impairment of Solute-Free Water Clearance in Patients With HIV InfectionCompletedNCT01869010
- Efficacy of the 6-point DietCompletedNCT01865526Not applicable
- Endovenous Versus Liposomal Iron in CKDCompletedNCT01864161Phase 4
- Vascular Protective Effect of Rosuvastatin in Arteriovenous FistulaCompletedNCT01863914Phase 2
- Effect of Intermittent Hemodialysis on Sleep Apnea Syndrome in End Stage Renal Disease PatientsCompletedNCT01860209Not applicable
- Optimizing Kidney Transplant Informed ConsentCompletedNCT01859884Not applicable
- Evaluation of a Website on Living Kidney Donation for HispanicsCompletedNCT01859871Not applicable
- Using Continuous Positive Airway Pressure to Reduce the Incidence of Acute Kidney Injury in Hospitalized Patients With Chronic Kidney DiseaseWithdrawnNCT01859260Not applicable
- Post Authorisation Safety Study of Renvela® in Chronic Kidney Disease Patients Not on Dialysis With HyperphosphataemiaCompletedNCT01857024
- L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRDWithdrawnNCT01855334Phase 4
- Protein Supplementation in Dialysis PatientsCompletedNCT01855295Not applicable
- The Effects of Mycophenolate Mofetil (MMF) on Renal Outcomes in Advanced Immunoglobulin A (IgA) Nephropathy PatientsCompletedNCT01854814Not applicable
- Communicating About Choices in TransplantationCompletedNCT01853007Not applicable
- Renal Sympathetic Denervation as a New Treatment for Therapy Resistant HypertensionCompletedNCT01850901Phase 3
- Deceased Donor Biomarkers and Recipient OutcomesCompletedNCT01848249
- Study of an Autologous Neo-Kidney Augment in Patients With Chronic Kidney DiseaseTerminatedNCT01846715Phase 1
- Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous NephropathyCompletedNCT01845688Not applicable
- Evaluation of Daily HemoDialysis at Low Dialysate Flow in Patients Previously Treated With Conventional HemodialysisTerminatedNCT01845012Not applicable
- The Effects of Dietary Fiber in CKD: A Systematic Review and Meta-analysisCompletedNCT01844882
- A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney DiseaseCompletedNCT01843790Phase 2
- Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic NephropathyCompletedNCT01843387Phase 1/2
- Care Transitions in Renal Disease PatientsStatus unknownNCT01842776
- The Effects of Fiber Fortified Foods to the Diets of Chronic Kidney Disease PatientsCompletedNCT01842087Not applicable
- Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal DiseaseCompletedNCT01840956Phase 1
- MSC for Occlusive Disease of the KidneyCompletedNCT01840540Phase 1